Wellington Management Group
LXRX icon

Wellington Management Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Wellington Management Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431K Buy
+179,700
New +$350K ﹤0.01% 1845
2025
Q3 		– Sell
-486,674
Closed -$460K – 2048
2025
Q2 		$460K Buy
+486,674
New +$315K ﹤0.01% 1832
2025
Q1 		– Sell
-747,996
Closed -$552K – 2004
2024
Q4 		$552K Buy
747,996
+15,249
+2% +$18.4K ﹤0.01% 1821
2024
Q3 		$1.15M Sell
732,747
-5,881
-0.8% -$10.5K ﹤0.01% 1682
2024
Q2 		$1.24M Buy
738,628
+52,210
+8% +$93.7K ﹤0.01% 1623
2024
Q1 		$1.65M Buy
+686,418
New +$1.47M ﹤0.01% 1568
2023
Q4 		– Sell
-378,701
Closed -$413K – 1889
2023
Q3 		$413K Buy
378,701
+236,695
+167% +$415K ﹤0.01% 1719
2023
Q2 		$325K Sell
142,006
-9,487
-6% -$25.2K ﹤0.01% 1733
2023
Q1 		$368K Sell
151,493
-4,413
-3% -$10.1K ﹤0.01% 1886
2022
Q4 		$298K Buy
155,906
+263
+0.2% +$560 ﹤0.01% 1897
2022
Q3 		$374K Sell
155,643
-61,554
-28% -$170K ﹤0.01% 1861
2022
Q2 		$404K Hold
217,197
– – ﹤0.01% 1883
2022
Q1 		$454K Buy
217,197
+1,656
+0.8% +$4.59K ﹤0.01% 1941
2021
Q4 		$849K Buy
+215,541
New +$1.05M ﹤0.01% 1831
2018
Q3 		– Sell
-244,516
Closed -$2.93M – 2273
2018
Q2 		$2.93M Sell
244,516
-84,913
-26% -$868K ﹤0.01% 1631
2018
Q1 		$2.82M Hold
329,429
– – ﹤0.01% 1643
2017
Q4 		$3.25M Buy
329,429
+212,174
+181% +$2.2M ﹤0.01% 1601
2017
Q3 		$1.44M Buy
+117,255
New +$1.73M ﹤0.01% 1799
2017
Q2 		– Sell
-279,874
Closed -$4.01M – 2260
2017
Q1 		$4.01M Buy
279,874
+27,964
+11% +$415K ﹤0.01% 1514
2016
Q4 		$3.48M Buy
251,910
+104
+0% +$1.67K ﹤0.01% 1528
2016
Q3 		$4.55M Buy
251,806
+12,629
+5% +$203K ﹤0.01% 1414
2016
Q2 		$3.43M Buy
+239,177
New +$3.24M ﹤0.01% 1464

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group's LXRX Position: Q2 2026 in Review

Wellington Management Group opened a new position in Lexicon Pharmaceuticals (LXRX) in Q2 2026: 179,700 shares worth $431K. The stake represents ﹤0.01% of the portfolio and ranks #1845 among its holdings. This is a return to the name: Wellington Management Group previously reported a position in LXRX as recently as Q2 2025.

Wellington Management Group first reported a position in LXRX in Q2 2016 and has held it in 22 quarters since. The position peaked at $4.55M in Q3 2016. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Wellington Management Group held 179,700 shares of Lexicon Pharmaceuticals worth $431K as of Q2 2026.
  • Lexicon Pharmaceuticals was a new Wellington Management Group position in Q2 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1845 holding.
  • Wellington Management Group first reported a position in Lexicon Pharmaceuticals in Q2 2016 and has held it in 22 quarters since.
  • Wellington Management Group's Lexicon Pharmaceuticals position peaked at $4.55M in Q3 2016.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.